TuisONCY • NASDAQ
add
Oncolytics Biotech Inc
Vorige sluiting
$1,01
Dagwisseling
$0,99 - $1,05
Jaarwisseling
$0,33 - $1,53
Markkapitalisasie
88,76 m USD
Gemiddelde volume
867,83 k
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 5,71 m | -27,95% |
Netto inkomste | -6,16 m | 15,04% |
Netto winsgrens | — | — |
Wins per aandeel | -0,07 | 28,86% |
EBITDA | -5,68 m | 28,02% |
Effektiewe belastingkoers | -1,40% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 14,63 m | -41,14% |
Totale bates | 19,97 m | -37,72% |
Totale aanspreeklikheid | 13,88 m | 0,92% |
Totale ekwiteit | 6,09 m | — |
Uitstaande aandele | 100,36 m | — |
Prys om te bespreek | 16,83 | — |
Opbrengs op bates | -71,91% | — |
Opbrengs op kapitaal | -197,15% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -6,16 m | 15,04% |
Kontant van bedrywe | -5,47 m | 19,77% |
Kontant van beleggings | — | — |
Kontant van finansiering | 5,37 m | 172,05% |
Netto kontantverandering | -677,00 k | 85,76% |
Beskikbare kontantvloei | -3,25 m | 28,13% |
Meer oor
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Gestig
1998
Hoofkwartier
Webwerf
Werknemers
28
